Meridian Laboratories Inc v. OncoGenerix USA, Inc

1:18-cv-06007

January 18, 2022
Pharma Co. Gets Partial Win In Cancer Drug Contract Fight

An Illinois federal judge granted OncoGenerix USA Inc. summary judgment on almost all claims in a suit alleging it violated an agreement with Meridian Laboratories Inc. to help develop a cancer treatment, saying Meridian can't back up its allegations that OncoGenerix misappropriated its confidential information.
June 28, 2021
Pharma Co. Says Contract Fight Can't Be Painted As Fraud

Drug manufacturer OncoGenerix USA Inc. urged an Illinois federal judge Friday to cut what it says are baseless allegations that it misappropriated confidential information from Meridian Laboratories Inc., which has accused the manufacturer of violating an agreement to help develop a cancer treatment.
May 14, 2020
Pharma Co. Must Face Fraud, Trade Secret Claims In Drug Suit

Drug manufacturing company OncoGenerix USA Inc. can't dodge accusations that it ruined a drug developer's shot at $10 million in milestone payments by misrepresenting its ability and willingness to help produce a new cancer treatment, an Illinois federal judge said Wednesday.

Law360